The Secret To Success In Obesity Drug Research

Obesity is now the fastest-growing area in clinical research, and competition for sites and eligible participants is intensifying. Keeping patients enrolled may be the biggest hurdle of all. Roughly half of participants in weight loss trials drop out within the first year; replacing a single dropout can cost more than $19,000, and trial delays can cost sponsors $800,000 per day in lost prescription drug sales.

Why do participants leave? Long study timelines, discouraging weight loss plateaus, medication side effects, demanding lifestyle changes, and heavy documentation all take a toll. Explore the practical and emotional barriers behind dropout and engagement strategies that help participants stay the course. Discover how a patient-centered retention approach can protect your timelines, your budget, and the quality of your obesity trial data.